| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/03/2006 | WO2006052363A3 Co-expression of multiple protein chains or subunits |
| 08/03/2006 | WO2006048657A3 Fras related protein |
| 08/03/2006 | WO2006045313A3 Uses of secretagogues for treatment of organ transplant patients |
| 08/03/2006 | WO2006034435A3 Methods and compositions for treating glucose-associated conditions, metabolic syndrome, dyslipidemias and other conditions |
| 08/03/2006 | WO2006029411A3 Mixtures of polypeptides, compositions containing and processes for preparing same, and uses thereof |
| 08/03/2006 | WO2006026426A3 Amyloid peptide inactivating enzyme to treat alzheimer’s disease peripherally |
| 08/03/2006 | WO2006020984A3 Cyclosporin formulations |
| 08/03/2006 | WO2006016930A3 Methods for treating hcv infection |
| 08/03/2006 | WO2006014839A3 Activated protein c inhibits undesirable effects of plasminogen activator in the brain |
| 08/03/2006 | WO2005117940A9 Cell death modulation via antagonists of fasl and fas activation |
| 08/03/2006 | WO2005117938A3 Methods of treating ocular conditions |
| 08/03/2006 | WO2005116655A3 Natriuretic compounds, conjugates, and uses thereof |
| 08/03/2006 | WO2005113007A3 Powders containing novel oligosaccharide mixtures and methods for producing the same |
| 08/03/2006 | WO2005112988A3 Methods for treating and diagnosing cancer with wnt inhibitory factor-1 (wif-1) |
| 08/03/2006 | WO2005110470A3 Methods and compositions for the modulation of immune responses and autoimmune diseases by activating rp105 (cd180) |
| 08/03/2006 | WO2005110452A3 MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFα-RELATED DISORDERS |
| 08/03/2006 | WO2005108428A3 Cd40 splice variants and their uses |
| 08/03/2006 | WO2005099749A3 Methods for controlling angiogenesis and cell proliferation |
| 08/03/2006 | WO2005097195A3 Methods of reducing aggregation of il-1ra |
| 08/03/2006 | WO2005094383A3 Hunter-killer peptides and methods of use |
| 08/03/2006 | WO2005079849A3 Compounds for enhanced cancer therapy |
| 08/03/2006 | WO2005073250A3 Medical treatment using an rna1 targeting a human notch signalling pathway member |
| 08/03/2006 | WO2005070444A8 Methods for treating acute myocardial infarction by calcitonin gene related peptide and compositions containing the same |
| 08/03/2006 | WO2005056756A3 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 08/03/2006 | WO2005037225A3 Methods for treating disorders of neuronal deficiency with bone marrow-derived cells |
| 08/03/2006 | WO2005016226A3 Pharmaceutical compositions comprising ccr5 antagonists |
| 08/03/2006 | WO2005009333A3 Combined treatments comprising synthetic peptide copolymers for preventing graft rejection |
| 08/03/2006 | WO2004060867A3 Secreted protein factor and cell membrane-bound splice variant |
| 08/03/2006 | WO2004039951A3 Il-1 receptor based antagonists and methods of making and using |
| 08/03/2006 | WO2004009614A3 Receptor (sstr4)- selective somatostatin analogs |
| 08/03/2006 | WO2004007746A3 METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IgE SYNTHESIS UTILIZING A B-CELL ASSOCIATED PROTEIN |
| 08/03/2006 | WO2004007680A3 Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing an adenosine kinase |
| 08/03/2006 | WO2004001381A8 Novel raag10 cell surface target and a family of antibodies recognizing that target |
| 08/03/2006 | WO2003014318A3 Methods for treating diabetes and other blood sugar disorders |
| 08/03/2006 | WO2003013425A3 In vitro assays for inhibitors of hiv capsid conformational changes and for hiv capsid formation |
| 08/03/2006 | WO2002102319A3 Polynucleotide encoding a novel human growth factor with homology to epidermal growth factor, bgs-8, expressed highly in immune tissue |
| 08/03/2006 | US20060174361 Transgenic mice containing adrenocorticotropin hormone receptor gene disruptions |
| 08/03/2006 | US20060173168 Bioactive peptides and unique ires elements from myelin proteolipid protein plp/dm20 |
| 08/03/2006 | US20060173162 Bactericidak anti-apoptotic, pro-inflammatory and anti-inflammatory peptides of heparin-binding protein (hbp) |
| 08/03/2006 | US20060173161 Protein-binding doxorubicin peptide derivatives |
| 08/03/2006 | US20060173160 Synthesis and characterization of novel systems for guidance and vectorization of molecules of therapeutic interest towards target cells |
| 08/03/2006 | US20060172972 Formulation and method for administration of ophthalmologically active agents |
| 08/03/2006 | US20060172966 Immunostimulatory G, U-containing oligoribonucleotides |
| 08/03/2006 | US20060172960 cellular senescence and immortalization; administering a telemerase inhibitor; reduced loss of telomere length; antiproliferative agents |
| 08/03/2006 | US20060172957 Antisense modulation of integrin beta 4 binding protein expression |
| 08/03/2006 | US20060172952 Aza-peptide epoxides |
| 08/03/2006 | US20060172951 Age related macular degeneration and cutaneous signs of mercury toxicity |
| 08/03/2006 | US20060172950 Hepatitis C virus inhibitors |
| 08/03/2006 | US20060172949 administering a protein agonist for protease-activated receptor (PAR-2); side effects reduction; peptidase inhibitors (amistatins); drug delivery; biodrugs as antisecretory agents |
| 08/03/2006 | US20060172948 Gamma-carboxyglutamate containing conopeptides |
| 08/03/2006 | US20060172947 Physiologically active peptides and drugs containing the same |
| 08/03/2006 | US20060172946 Having serine protease inhibitory activity |
| 08/03/2006 | US20060172945 Human neutrophil alpha-defensin 4 inhibition of HIV-1 |
| 08/03/2006 | US20060172944 Locally administering an effective amount of an agent capable of blocking or inhibiting vascular endothelial growth factor (VEGF)-mediated activity to a subject in need thereof, such that the eye injury is ameliorated or improved |
| 08/03/2006 | US20060172943 Restoring vascular function |
| 08/03/2006 | US20060172942 Process for producing polypeptide mixtures using hydrogenolysis |
| 08/03/2006 | US20060172940 Glycosylated mucocidin antimicrobial peptide, ophthalmic formulation, inhibiting microbial growth |
| 08/03/2006 | US20060172939 Methods and apparatus for creating particle derivatives of HDL with reduced lipid content |
| 08/03/2006 | US20060172938 Peptide inhibitors against seprase |
| 08/03/2006 | US20060172937 Relates to peptides which bind to MHC molecules of either Class I or Class II; the peptides consist of amino acid sequences found in the NY-ESO-1 molecule; useful in treating cancerous conditions |
| 08/03/2006 | US20060172936 e.g. hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-3-(cyclopentyloxy)[(3-[2-(dimethylamino)ethyl]aminophenyl)sulfonyl]amino-2-hydroxypropyl)carbamate; against human immunodeficiency virus, chronic and acute viral infections |
| 08/03/2006 | US20060172935 Screening and therapeutic methods for treating circadian rhythm disorders |
| 08/03/2006 | US20060172934 Method and kit for repairing a defect in bone |
| 08/03/2006 | US20060172933 Natriuretic compounds, conjugates, and uses thereof |
| 08/03/2006 | US20060172932 Novel erythropoietin receptor agonists |
| 08/03/2006 | US20060172931 Heparin-binding peptides and uses thereof |
| 08/03/2006 | US20060172930 Apoptosis-inducing gene and utilization of the same |
| 08/03/2006 | US20060172929 Use of natriuretic peptides for the treatment of stature disorders related to the shox gene |
| 08/03/2006 | US20060172928 providing a biomolecule such as nucleic acid, protein, antibody immobilized on a substrate (quartz, glass etc) covering with a nonreducing disaccharide trehalose or sucrose; a protein or peptide of Late Embryogenesis Abundant (LEA) class comprising a motif of 11 amino acids; biochip; storage stability |
| 08/03/2006 | US20060172927 Analogs of human growth hormone-releasing hormone, their preparation and use |
| 08/03/2006 | US20060172926 Aplidine for multiple myeloma treatment |
| 08/03/2006 | US20060172924 Reducing hypotensive events experienced by normovolemic subject during surgery while under general anesthesia via modified hemoglobin |
| 08/03/2006 | US20060172923 Method of activating insulin receptor substrate-2 to stimulate insulin production |
| 08/03/2006 | US20060172922 Methods for combating ischemic injury to epithelial organ |
| 08/03/2006 | US20060172921 Method for identifying active anti-apoptosis compounds |
| 08/03/2006 | US20060172920 Oxidised lipids as reversal agents for boronic acid drugs |
| 08/03/2006 | US20060172919 treating non-cancerous diseases which symptoms include an increase in angiogenesis, e.g., psoriasis, retinopathy of prematurity, neovascular glaucoma, diabetic retinopathy, obesity |
| 08/03/2006 | US20060172918 Composite biomaterials |
| 08/03/2006 | US20060172395 Enriched nucleic acid comprising a nucleotide complementary sequence, encoding a polypeptide from:an adenylating amide synthetase or an isoprenyl transferase |
| 08/03/2006 | US20060172391 BMP-11 compositions |
| 08/03/2006 | US20060172390 Consensus phytases |
| 08/03/2006 | US20060172389 Canine erythropoietin gene and recombinant protein |
| 08/03/2006 | US20060172386 Human FGF-20 gene and gene expression products |
| 08/03/2006 | US20060172378 Variants of protein kinases |
| 08/03/2006 | US20060172360 Mkk7 activation inhibitor |
| 08/03/2006 | US20060172355 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/03/2006 | US20060172354 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/03/2006 | US20060172348 incubating a cell or tissue sample with a purified antibody or an antigen binding fragment that binds specifically to a portion of human NAIP protein, detecting binding of antibody to such cell or tissue sample |
| 08/03/2006 | US20060172346 Methods of designing and producing novel compounds having improved binding affinity for CD154 or other trimeric proteins |
| 08/03/2006 | US20060172343 Isolated using polymerase chain reaction using primers ; gene therapy; wound heaaling agents |
| 08/03/2006 | US20060172323 Identification of compounds that modify transcriptional responses to hypoxia |
| 08/03/2006 | US20060172304 Method for modulating epithelial stem cell lineage |
| 08/03/2006 | US20060172301 Secreted acid phosphatse (sapm) is present only in pathogenic mycobacteria and expressed selectively at phagosomal ph |
| 08/03/2006 | US20060172300 Method for identifying bhs-specific proteins and fragments thereof |
| 08/03/2006 | US20060172298 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
| 08/03/2006 | US20060172291 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications |
| 08/03/2006 | US20060172011 Medical treatment |
| 08/03/2006 | US20060172008 formed from plasma proteins comprising fibrinogen, thrombin and Factor XIII, the matrix having less than 10% residual moisture and being devoid of external anti-fibrinolytic agents; sponges; useful as cell-bearing implants |
| 08/03/2006 | US20060172004 Oral compositions for the stimulation of gastric acid secretion comprising pentagastrin |
| 08/03/2006 | US20060172001 Novel methods and compositions for enhanced transmucosal delivery of peptides and proteins |